pmid,title,journal,year,drug,disease
36972545,Drug Repurposing and Observational Studies: The Case of Antivirals for the Treatment of COVID-19.,Annals of internal medicine,2023,Molnupiravir,Tuberculosis
36410382,What Clinicians Need to Know About the Development of Long-Acting Formulations.,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,2022,Molnupiravir,Tuberculosis
36193938,Confronting antimicrobial resistance together.,American journal of physiology. Lung cellular and molecular physiology,2022,Molnupiravir,Tuberculosis
34902743,RdRp inhibitors and COVID-19: Is molnupiravir a good option?,Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,2022,Molnupiravir,Tuberculosis
32887691,A living WHO guideline on drugs for covid-19.,BMJ (Clinical research ed.),2020,Molnupiravir,Tuberculosis
